Detalhe da pesquisa
1.
Identification of the atypically modified autoantigen Ars2 as the target of B-cell receptors from activated B-cell-type diffuse large B-cell lymphoma.
Haematologica
; 106(8): 2224-2232, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32675228
2.
Autoantibodies against lamin C, NA14 and CK15 in primary vasculitides or autoimmune diseases with secondary vasculitis.
Clin Exp Rheumatol
; 34(3 Suppl 97): S60-9, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27214601
3.
CD4⺠T cells in chronic autoantigenic stimulation in MGUS, multiple myeloma and Waldenström's macroglobulinemia.
Int J Cancer
; 137(5): 1076-84, 2015 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25677163
4.
The molecular basis for development of proinflammatory autoantibodies to progranulin.
J Autoimmun
; 61: 17-28, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26005049
5.
Management of diffuse large B-cell lymphoma (DLBCL).
Cancer Treat Res
; 165: 271-88, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25655614
6.
EBV-transformed lymphoblastoid cell lines as vaccines against cancer testis antigen-positive tumors.
Cancer Immunol Immunother
; 62(7): 1211-22, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23619976
7.
REFLECT: prospective multicenter non-interventional study evaluating the effectiveness and safety of Sandoz rituximab (SDZ-RTX; Rixathon®) in combination with CHOP for the treatment of patients with previously untreated CD20-positive diffuse large B-cell lymphoma.
Ther Adv Hematol
; 14: 20406207231183765, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37492394
8.
Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial.
Nat Commun
; 14(1): 6761, 2023 10 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37875494
9.
Cryptic epitopes induce high-titer humoral immune response in patients with cancer.
J Immunol
; 185(5): 3095-102, 2010 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20660712
10.
B-cell receptors of EBV-negative Burkitt lymphoma bind modified isoforms of autoantigens.
EJHaem
; 3(3): 739-747, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36051037
11.
A peptide epitope derived from the cancer testis antigen HOM-MEL-40/SSX2 capable of inducing CD4⺠and CD8⺠T-cell as well as B-cell responses.
Cancer Immunol Immunother
; 60(9): 1333-46, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21630107
12.
Analysis of the antibody repertoire of patients with mantle cell lymphoma directed against mantle cell lymphoma-associated antigens.
Ann Hematol
; 88(10): 999-1003, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19238384
13.
KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis.
Leukemia
; 33(5): 1124-1134, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30635631
14.
Naturally occurring T-cell response against mutated p21 ras oncoprotein in pancreatic cancer.
Clin Cancer Res
; 12(4): 1365-72, 2006 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16489095
15.
Learning from the failures of drug discovery in B-cell non-Hodgkin lymphomas and perspectives for the future: chronic lymphocytic leukemia and diffuse large B-cell lymphoma as two ends of a spectrum in drug development.
Expert Opin Drug Discov
; 12(7): 733-745, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28494631
16.
Sumoylated HSP90 is a dominantly inherited plasma cell dyscrasias risk factor.
J Clin Invest
; 125(1): 316-23, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25485683
17.
Use of spontaneous Epstein-Barr virus-lymphoblastoid cell lines genetically modified to express tumor antigen as cancer vaccines: mutated p21 ras oncogene in pancreatic carcinoma as a model.
Hum Gene Ther
; 13(7): 815-27, 2002 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11975848
18.
Expression of cancer-testis genes in human hepatocellular carcinomas.
Cancer Immun
; 2: 11, 2002 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-12747756
19.
Identification of an HLA-A*02 restricted immunogenic peptide derived from the cancer testis antigen HOM-MEL-40/SSX2.
Cancer Immun
; 3: 18, 2003 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-14677925
20.
Rapid identification of preformed alloreactive T cells for use in a clinical setting.
Transplantation
; 78(4): 607-14, 2004 Aug 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-15446322